Overview
- 3 inspections across 3 sites are on record.
- 1 Form 483 observation is attributed to this investigator.
- Most recent recorded activity is 2025-10-29.
At a glance
Inspections
3
Sites
3
Observations
1
Career since
Dec 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Shenyang Sunshine Pharmaceutical Co., Ltd. | 29 Oct 2025 | Human Drugs | On file |
| Teva Biotech GmbH | 21 Mar 2025 | Human Drugs | On file |
| Biomarin Pharmaceutical Inc. | 14 Dec 2017 | Human Drugs | On file |
Sites inspected
Shenyang Sunshine Pharmaceutical Co., Ltd.Shenyang, China1 insp.
Teva Biotech GmbHUlm, Germany1 insp.
Biomarin Pharmaceutical Inc.Novato, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Wayne E Seifert1 shared
Bo Chi1 shared
Joslyn K Brunelle1 shared
Jolanna A Norton1 shared
Ashar P Parikh1 shared
Full investigator report
Get the verbatim findings behind Ying Xin Fan's 1 observation
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site